-+ 0.00%
-+ 0.00%
-+ 0.00%

RALLYBIO COMPLETES DOSING OF FIRST COHORT IN RLYB116 PHASE 1 CONFIRMATORY PHARMACOKINETIC/PHARMACODYNAMIC STUDY

Reuters·09/25/2025 12:00:46

Please log in to view news